Sort
40,608 grants matching “prostate cancer”
CLARIFYING MECHANISMS OF BET BROMODOMAIN INHIBITOR RESPONSE IN CASTRATION-RESISTANT PROSTATE CANCER
$577,499Oregon Health & Science University · · FY2016 · Department of Defense
N-CADHERIN IN PROSTATE CANCER: DOWNSTREAM PATHWAYS AND THEIR TRANSLATIONAL APPLICATION FOR CASTRATE-RESISTANT PROSTATE CANCER
$577,417University Of California, Los Angeles · · FY2009 · Department of Defense
THE INFLUENCE OF HOME-BASED AEROBIC AND RESISTANCE EXERCISE ON CANCER-RELATED FATIGUE, STRENGTH, AND MUSCLE MASS IN PROSTATE PATIENTS DURING RADIOTHE
$577,416University Of Rochester · · FY2008 · Department of Defense
Mechanisms of resistance to treatment in aggressive prostate cancers
$577,402Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Molecular alterations driving the development of primary prostate cancers
$577,402Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Etiologic Studies of Prostate Cancer
$577,301Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Image-guided TRAIL-enhanced CAR T-cell immunotherapy
$577,130Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Precision Prostate Cancer Screening with Genetically Adjusted Prostate-Specific Antigen Levels
$577,096John S Witte · Stanford University · R01 · FY2022 · CA
ELUCIDATING THE FUNCTIONAL ROLE OF POU3F2 IN SMALL CELL/NEUROENDOCRINE PROSTATE CANCER DIFFERENTIATION
$577,053University Of California, Los Angeles · · FY2016 · Department of the Army
Radiation, Hormones &Antisense Prostate Cancer Therapy
$576,986Fox Chase Cancer Center · R01 · FY2005 · CA
Molecular imaging of novel PARP inhibitor nanomedicine delivery
$576,944Henry F. Vanbrocklin · University Of California, San Francisco · R01 · FY2022 · CA
Biostatistics
$576,926Gary L Rosner · Johns Hopkins University · P30 · FY2024 · CA
Biostatistics
$576,926Gary L Rosner · Johns Hopkins University · P30 · FY2023 · CA
Biostatistics
$576,926Gary L Rosner · Johns Hopkins University · P30 · FY2022 · CA
Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer
$576,689Marja T Nevalainen · Medical College Of Wisconsin · R01 · FY2022 · CA
RSK2 IN PROSTATE CANCER
$576,682The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2009 · Department of Defense
Protein kinase C signaling in prostate cancer health disparities
$576,595Marcelo Gabriel Kazanietz · University Of Miami School Of Medicine · R01 · FY2024 · CA
FUNCTIONAL MECHNANISM AND CLINICAL CORRELATION OF TAP/SEC 14L2 IN PROSTATE CANCER
$576,558University Of Rochester · · FY2008 · Department of Defense
ENVIRONMENT &GLI GENES IN NORMAL DEVELOPMENT &DISEASE
$576,454Children'S Memorial Hospital (Chicago) · P01 · FY2003 · ES
PROSTATE CANCER BIOREPOSITORY NETWORK (PCBN)
$576,450Institute Of Cancer Research: Royal Cancer Hospital (The) · · FY2018 · Department of the Army
HIGH-THROUGHPUT IDENTIFICATION AND CHARACTERIZATION OF NOVEL ANTI-PROSTATE CANCER THERAPEUTICS
$576,400University Of California, San · · FY2009 · Department of the Army
RADIATION EFFECTS OM THE IMMUNE RESPONSE TO PROSTATE CANCER
$576,329University Of California, Los Angeles · · FY2008 · Department of Defense
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER INTOBAGONIANS
$576,271University Of Pittsburgh At Pittsburgh · R01 · FY2000 · CA
PROGRESSION OF BPH ON MEDICAL THERAPY
$576,268Columbia University Health Sciences · U01 · FY2001 · DK
Hybrid Nanoparticles in Imaging and Therapy of Prostate*
$576,194Kattesh V Katti · University Of Missouri-Columbia · R01 · FY2008 · CA